logo

Fluidigm Corp. (FLDM)



Trade FLDM now with
  Date
  Headline
8/1/2019 8:38:44 AM Fluidigm To Introduce RNA-seq Library Preparation Workflow In Q3
2/12/2019 11:01:10 PM Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/7/2019 9:07:05 AM Fluidigm Announces Co-Marketing Agreement With Indica Labs
12/12/2018 1:19:16 AM Fluidigm Announces Pricing Of Public Offering Of 8.15 Mln Shares At $6.75/shr
12/12/2018 1:02:49 AM Fluidigm Prices Underwritten Public Offering Of 8.15 Mln Shares At $6.75/shr
12/11/2018 4:10:13 PM Fluidigm Commences Public Offering Of Common Stock
10/31/2018 8:34:09 AM Fluidigm Appoints Laura Clague To Board
10/4/2018 8:34:17 AM Fluidigm Enters Non-exclusive Distribution Agreement With DNA Software
9/10/2018 8:33:12 AM Fluidigm Announces Co-Marketing Deal With Visiopharm To Expand And Simplify Imaging Mass Cytometry Data Analysis
9/7/2018 7:34:41 AM Fluidigm Partners With GenomOncology To Provide A Comprehensive Immuno-Oncology Gene Expression Solution
6/26/2018 8:37:01 AM David King Joins Fluidigm As VP, Research And Development, Genomics
6/7/2018 7:10:14 AM Fluidigm Enters Co-marketing Agreement With Genomenon
4/23/2018 8:14:05 AM Brad Kreger Joins Fluidigm As SVP, Global Operations
3/2/2018 7:48:31 AM Fluidigm Reports Exchange Of Convertible Notes
1/7/2016 12:31:54 PM Deutsche Bank Starts Fluidigm Corp. (FLDM) At Buy With $18 Price Target
10/30/2014 8:51:29 PM Fluidigm Corp. (FLDM) Has Raised Its 2014 Revenue Estimate To $114 - $117 Mln From $112 - $118 Mln
2/15/2012 1:49:48 PM Deutsche Bank Is Increasing Fluidigm Corp. (FLDM) FY 13 Rev. Estimate To 69.5 M From 65.5 M
2/15/2012 1:49:43 PM Deutsche Bank Is Raising Fluidigm Corp. (FLDM) FY 12 Rev. Estimate To 53.5 M From 51.5 M
  
 
>